Clinical trial
Functional and Neurodevelopmental Outcomes Following Intensive Multimodal Neurorehabilitation in Pediatric Patients With Neurodevelopmental Disorders, Including Chromosomal Abnormalities
NCT07493096 is registered in ClinicalTrials.gov with Healing Hope International as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Functional and Neurodevelopmental Outcomes Following Intensive Multimodal Neurorehabilitation in Pediatric Patients With Neurodevelopmental Disorders, Including Chromosomal Abnormalities
- Lead sponsor
- Healing Hope International
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- March 1, 2026
- Completion date
- December 30, 2036
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
22q11.2 deletion syndrome, autism spectrum disorder, autism spectrum disorder (asd, cerebral palsy (cp), cerebral palsy hemiparetic cerebral palsy spasticity gait disorders, neurologic postural balance impairment, cerebral palsy infantile, cerebral palsy spastic hemiplegic, cerebral palsy, dyskinetic, chromosomal abnormalities, developmental delay (disorder), down syndrome (trisomy 21), fragile x syndrome (fxs), genetic disorders, hypoxic ischemic encephalopathy, hypoxic ischemic encephalopathy (hie), neurodevelopmental disorders, neurodevelopmental disorders (ndd), neurodevelopmental disorders and developmental abnormalities, rett syndrome with proven mecp2 mutation, sensorimotor integration, sensory processing disorder, traumatic brain injury (tbi), williams syndrome